Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-19
DOI
10.1111/bju.14400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
- (2018) Silke Gillessen et al. EUROPEAN UROLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reply to the letter to the editor ‘Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy’ by Tannock et al.
- (2016) C. Parker et al. ANNALS OF ONCOLOGY
- Chemotherapy at First Diagnosis of Advanced Prostate Cancer – Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer
- (2016) R. Davda et al. CLINICAL ONCOLOGY
- Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
- (2016) Gwenaelle Gravis et al. EUROPEAN UROLOGY
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- (2016) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Comparison of SEER Treatment Data With Medicare Claims
- (2016) Anne-Michelle Noone et al. MEDICAL CARE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Oligometastatic prostate cancer: definitions, clinical outcomes and treatment considerations
- (2016) Jeffrey J. Tosoian et al. Nature Reviews Urology
- Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis
- (2016) Arif Hussain et al. Cancer Medicine
- Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy
- (2015) I. F. Tannock et al. ANNALS OF ONCOLOGY
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
- (2015) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
- (2015) Nicholas David James et al. EUROPEAN UROLOGY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- MatchIt: Nonparametric Preprocessing for Parametric Causal Inference
- (2015) Daniel E. Ho et al. Journal of Statistical Software
- Overview of breast cancer collaborative stage data items-their definitions, quality, usage, and clinical implications: A review of SEER data for 2004-2010
- (2014) Nadia Howlader et al. CANCER
- The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer
- (2013) Gregory R. Pond et al. EUROPEAN UROLOGY
- US Food and Drug Administration Approval of Drugs for the Treatment of Prostate Cancer: A New Era Has Begun
- (2013) Anthony V. D'Amico JOURNAL OF CLINICAL ONCOLOGY
- Distribution of metastatic sites in patients with prostate cancer: A population-based analysis
- (2013) Giorgio Gandaglia et al. PROSTATE
- Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
- (2010) Peter C. Austin PHARMACEUTICAL STATISTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now